Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ACHR | XENE |
|---|---|---|
| Price | $4.72 | $37.57 |
| Change today | ▼ 3.48% | ▼ 1.18% |
| Market cap | $3.63B | $3.64B |
| Return, 3 months | -4.3% | -40.7% |
| Return, year to date | -37.2% | -16.2% |
| Return, 1 year | -65.4% | -5.0% |
| P/E (TTM) | -4.4 | -7.9 |
| P/B | 1.9 | 2.9 |
| P/E percentile vs own 5y | – | 100th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | -47.6% |
| Gross margin | – | – |
| Operating margin | – | -4,974.3% |
| Net margin | – | -4,612.1% |
| Return on equity | – | -43.6% |
| Analyst target vs. price | +145.8% | +97.0% |
| Analyst buy share | 83% | 100% |
| RSI (14) | 33 | 24 |
| 30-day volatility | 45.2% | 111.7% |
| Max drawdown, 1 year | -67.4% | -48.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
